Matinas BioPharma
MTNB
MTNB
28 hedge funds and large institutions have $618K invested in Matinas BioPharma in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.06% more ownership
Funds ownership: 5.43% → 6.49% (+1.1%)
Holders
28
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$32.5K | |
| 2 | +$18.1K | |
| 3 | +$15.5K | |
| 4 |
Renaissance Technologies
New York
|
+$5.17K |
| 5 |
Citigroup
New York
|
+$1.81K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SS
26
SBI Securities
Tokyo,
Japan
| $21 |
|
|||
27
Fidelity Investments
Boston,
Massachusetts
| $9 |
|
|||
|
MCM
28
MAI Capital Management
Independence,
Ohio
| $4 |
|
|||
29
Raymond James Financial
St Petersburg,
Florida
| – |
|